Clinical Trial Results:
            A PHASE 2A, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE DOSE, 5-WAY CROSSOVER STUDY ASSESSING THE PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILES OF ORAL INHALED PF-03635659 IN PATIENTS WITH MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2009-014540-11 | 
    Trial protocol  | 
        DE | 
    Global completion date  | 
        
                                    15 Jun 2010
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    05 Aug 2016
                             
         | 
    
    First version publication date  | 
        
                                    05 Aug 2016
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                B0431010 Public Disclosure Synopsis | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.